RFA
CDLX icon

Register Financial Advisors’s Cardlytics CDLX Stock Holding History

Register Financial Advisors’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10
Closed -$821 – 370
2024
Q2 		$821 Hold
10
– – ﹤0.01% 698
2024
Q1 		$1.45K Buy
+10
New +$844 ﹤0.01% 695
2023
Q4 		– Sell
-10
Closed -$1.65K – 359
2023
Q3 		$1.65K Hold
10
– – ﹤0.01% 528
2023
Q2 		$632 Hold
10
– – ﹤0.01% 522
2023
Q1 		$340 Hold
10
– – ﹤0.01% 531
2022
Q4 		$578 Buy
+10
New +$618 ﹤0.01% 769

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
BCM
Brightlight Capital Management Westport, Connecticut $101M AUM 23.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Register Financial Advisors's CDLX Position: Q3 2024 in Review

Register Financial Advisors sold out of Cardlytics (CDLX) in Q3 2024, closing a stake of 10 shares — an estimated $821 sold.

Register Financial Advisors first reported a position in CDLX in Q4 2022 and held it in 6 quarters. The position peaked at $1.65K in Q3 2023. 111 funds tracked by Wall St. Rank hold CDLX as of Q3 2024.

  • Register Financial Advisors reported no remaining Cardlytics position as of Q3 2024 after selling out during the quarter.
  • Register Financial Advisors sold 10 Cardlytics shares in Q3 2024, an estimated $821.
  • Register Financial Advisors first reported a position in Cardlytics in Q4 2022 and held it in 6 quarters.
  • Register Financial Advisors's Cardlytics position peaked at $1.65K in Q3 2023.
  • 111 funds tracked by Wall St. Rank held Cardlytics as of Q3 2024.

Based on Register Financial Advisors's 13F filing for Q3 2024, filed 15 Oct 2024.